Millions of people worldwide are diagnosed with cancer every year. In advanced tumor diseases, cancer cells detach from the ...

Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune ...

Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...

Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or ...

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...

The investigational GSK-3-beta inhibitor elraglusib can extend overall survival when added to standard first-line ...

While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

A groundbreaking study reveals that sacituzumab govitecan and pembrolizumab significantly enhance survival in untreated metastatic triple-negative breast cancer patients.

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim ...